Fibromyalgia Treatment Effective at Reducing Pain and Symptoms Shows Promise

Detailed results of the randomized, double-blinded, placebo-controlled Phase II study, known as PRID-201, were presented today at the 2014 American College of Rheumatology annual meeting in Boston by William L. Pridgen, M.D., FACS, founder and CEO of Innovative Med Concepts.
Source: Disabled World - Category: Disability Tags: Clinical Trials Source Type: news